Search results for CD69

Spark PLUS V475™ anti-mouse CD69 Recombinant Antibody, CD69, QA17A41, BioLegend, 164208

Biotin Anti-CD69 antibody [EPR21814], Abcam, AB316301

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Biotin Anti-CD69 antibody [H1.2F3], Abcam, AB25008

ab25008 augments PMA-induced T-cell proliferation and induces redirected lysis of Fc receptor-bearing target cells by NK cells.

PE Anti-CD69 antibody [EPR21811], Abcam, AB320280

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

PE Anti-CD69 antibody [FN50], Abcam, AB135932

The antibody is conjugated with R-Phycoerythrin (PE) under optimum conditions.

PE Anti-CD69 antibody [H1.2F3], Abcam, AB272258

APC Anti-CD69 antibody [EPR21811], Abcam, AB320281

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

APC Anti-CD69 antibody [FN50], Abcam, AB95609

Excitation: 633 nm Emission: 660 nm.

APC Anti-CD69 antibody [H1.2F3], Abcam, AB95611

FITC Anti-CD69 antibody [FN50], Abcam, AB135931